OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Survivin; a novel therapeutic target that correlates with survival of autoreactive T lymphocytes obtained from patients with ankylosing spondylitis
Navid Shomali, Behzad Baradaran, Amin Daei Sorkhabi, et al.
Gene (2022) Vol. 844, pp. 146829-146829
Closed Access | Times Cited: 11
Navid Shomali, Behzad Baradaran, Amin Daei Sorkhabi, et al.
Gene (2022) Vol. 844, pp. 146829-146829
Closed Access | Times Cited: 11
Showing 11 citing articles:
The current landscape of CAR T-cell therapy for solid tumors: Mechanisms, research progress, challenges, and counterstrategies
Amin Daei Sorkhabi, Leila Mohamed Khosroshahi, Aila Sarkesh, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 102
Amin Daei Sorkhabi, Leila Mohamed Khosroshahi, Aila Sarkesh, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 102
Mesenchymal stem cell-released oncolytic virus: an innovative strategy for cancer treatment
Nadia Ghasemi Darestani, Anna I. Gilmanova, Moaed E. Al‐Gazally, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 37
Nadia Ghasemi Darestani, Anna I. Gilmanova, Moaed E. Al‐Gazally, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 37
CXC chemokine receptor 4 (CXCR4) blockade in cancer treatment
Shunshun Bao, Mohammad Darvishi, Ali H. Amin, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 10, pp. 7945-7968
Closed Access | Times Cited: 18
Shunshun Bao, Mohammad Darvishi, Ali H. Amin, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 10, pp. 7945-7968
Closed Access | Times Cited: 18
Recent findings on chimeric antigen receptor (CAR)-engineered immune cell therapy in solid tumors and hematological malignancies
Ali Keshavarz, Ali Salehi, Setareh Khosravi, et al.
Stem Cell Research & Therapy (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 24
Ali Keshavarz, Ali Salehi, Setareh Khosravi, et al.
Stem Cell Research & Therapy (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 24
The various role of microRNAs in breast cancer angiogenesis, with a special focus on novel miRNA-based delivery strategies
Min Yang, Ying Zhang, Min Li, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 12
Min Yang, Ying Zhang, Min Li, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 12
Caspase family in autoimmune diseases
Wangzheqi Zhang, Huang Wu, Yan Liao, et al.
Autoimmunity Reviews (2024) Vol. 24, Iss. 2, pp. 103714-103714
Closed Access | Times Cited: 4
Wangzheqi Zhang, Huang Wu, Yan Liao, et al.
Autoimmunity Reviews (2024) Vol. 24, Iss. 2, pp. 103714-103714
Closed Access | Times Cited: 4
Role of SEL1L in the progression of solid tumors, with a special focus on its recent therapeutic potential
Darmadi Darmadi, Raed Obaid Saleh, Enwa Felix Oghenemaro, et al.
Cell Biology International (2024)
Closed Access | Times Cited: 1
Darmadi Darmadi, Raed Obaid Saleh, Enwa Felix Oghenemaro, et al.
Cell Biology International (2024)
Closed Access | Times Cited: 1
Advances in immune checkpoint-based immunotherapies for multiple sclerosis: rationale and practice
Amin Daei Sorkhabi, Erfan Komijani, Aila Sarkesh, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 3
Amin Daei Sorkhabi, Erfan Komijani, Aila Sarkesh, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 3
Molecular mechanisms of long non-coding RNAs in differentiation of T Helper17 cells
Mohamed J. Saadh, Meryelem Tania Churampi Arellano, Ravinder Saini, et al.
International Immunopharmacology (2023) Vol. 123, pp. 110728-110728
Closed Access | Times Cited: 2
Mohamed J. Saadh, Meryelem Tania Churampi Arellano, Ravinder Saini, et al.
International Immunopharmacology (2023) Vol. 123, pp. 110728-110728
Closed Access | Times Cited: 2
Gastric cancer combination therapy by siRNA-mediated NRF2 silencing and paclitaxel
Shima Hasani, Mohammad Khalaj‐Kondori, Sahar Safaei, et al.
Research Square (Research Square) (2023)
Open Access
Shima Hasani, Mohammad Khalaj‐Kondori, Sahar Safaei, et al.
Research Square (Research Square) (2023)
Open Access
Gastric cancer combination therapy by siRNA-mediated NFE2L2(NRF2) silencing and paclitaxel
Shima Hasani, Mohammad Khalaj‐Kondori, Sahar Safaei, et al.
Research Square (Research Square) (2023)
Open Access
Shima Hasani, Mohammad Khalaj‐Kondori, Sahar Safaei, et al.
Research Square (Research Square) (2023)
Open Access
